Literature DB >> 32638204

Age is a determinant of short-term mortality in patients hospitalized for an acute exacerbation of COPD.

Ernesto Crisafulli1,2, Alessandra Manco3, Mónica Guerrero4, Adrian Ceccato4, Arturo Huerta4, Albert Gabarrús4, Domenico Girelli2, Néstor Soler4, Antoni Torres5.   

Abstract

Several factors worsen the prognosis of hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD). Little is known about the specific contribution of age. Study aim was to evaluate the impact of age on early mortality (90-days).
METHODS: this observational prospective study considered hospitalized AECOPD patients. Three groups were created according to tertiles of age distribution: group 1 (≤ 67 years), group 2 (68-76 years) and group 3 (≥ 77 years). Baseline, clinical, microbiological, gas analysis and laboratory variables were collected at admission. The primary outcome was mortality at 90 days from admission. Multivariate regression models and receiver-operating characteristic (ROC) curves were used to evaluate the predictive power of age versus early mortality and adjusted for gender, comorbidities, staging and disease severity.
RESULTS: we enrolled 449 patients, 33 (7%) of whom died within 90 days from admission. Older patients were predominantly male, with more comorbidities, and higher dyspnoea grade and disease severity. The multivariate logistic regression demonstrated a significant predictive role of age as a continuous variable [odds ratio (OR) 1.05, 95% confidence interval (CI) 1.01-1.10; p = 0.046]. The Cox regression analysis found that group 2 [hazard ratio (HR) 6.6; 95% CI 1.5-28.8; p = 0.013], group 3 (HR 7.2; 95% CI 1.6-32.6; p = 0.010) and acute severe hypoxemia at admission (HR 2.7; 95% CI 1.2-6; p = 0.012) were independent significant predictors of mortality. The Kaplan-Meier curves showed a significant role of age in cumulative survival (Gehan-Breslow-Wilcoxon test p = 0.010). ROC curves highlighted 70 years as the best discriminating cut-off.
CONCLUSIONS: age is a determinant of worse prognosis among hospitalized patients with AECOPD.

Entities:  

Keywords:  Acute exacerbation; Age; Chronic obstructive pulmonary disease; Early mortality; Prognosis

Year:  2020        PMID: 32638204     DOI: 10.1007/s11739-020-02420-1

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  4 in total

1.  Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation.

Authors:  E Crisafulli; S Costi; F Luppi; G Cirelli; C Cilione; O Coletti; L M Fabbri; E M Clini
Journal:  Thorax       Date:  2008-01-18       Impact factor: 9.139

Review 2.  Epidemiology and clinical impact of major comorbidities in patients with COPD.

Authors:  Miranda Caroline Smith; Jeremy P Wrobel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-08-27

Review 3.  Acute exacerbation of COPD: is it the "stroke of the lungs"?

Authors:  Georgios Hillas; Fotis Perlikos; Nikolaos Tzanakis
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-07-13

4.  Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study.

Authors:  Ernesto Crisafulli; Antonella Ielpo; Enric Barbeta; Adrian Ceccato; Arturo Huerta; Albert Gabarrús; Néstor Soler; Alfredo Chetta; Antoni Torres
Journal:  Respir Res       Date:  2018-12-27
  4 in total
  2 in total

1.  Nomograms for Predicting Coexisting Cardiovascular Disease and Prognosis in Chronic Obstructive Pulmonary Disease: A Study Based on NHANES Data.

Authors:  Yuanjie Qiu; Yan Wang; Nirui Shen; Qingting Wang; Limin Chai; Jian Wang; Qianqian Zhang; Yuqian Chen; Jin Liu; Danyang Li; Huan Chen; Manxiang Li
Journal:  Can Respir J       Date:  2022-06-09       Impact factor: 2.130

2.  Serum Creatinine/Cystatin C Ratio as a Predictor of In-hospital Mortality in Patients Hospitalized with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Zhixiang Chen; Lei Zha; Xiao Ma; Jing Xu; Dandan Huang; Wenlong Wu; Long Chen; Feng Yang; Weiling Liao; Wenhua Wang
Journal:  Lung       Date:  2022-09-15       Impact factor: 3.777

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.